67 results
Page 2 of 4
8-K
EX-10.2
7f5lkd
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.1
o1qpsg4
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
5mg5 vhq884alpqk3z
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.6
5thllh67drn1zro2g
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.1
bq8em4aq3nqc97uprnq
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
j8y92h6
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
DEF 14A
4mmuc47j3ewpgoyfm7t
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
u0lfkd9raf4xkn3mk9
9 Apr 21
Preliminary proxy
4:16pm
424B4
7y4x1 9y3i4x
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
es66vp9 m4
25 Mar 21
Draft registration statement
12:00am
8-K
EX-10.10
j8tke2cqmxpupt
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
23sh 9qivhkvn
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
904ojqct3fr er
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
4tg5phc
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.1
0n9mh
23 Nov 20
Registration of securities for employees
5:06pm